AMY JOHNSON: Open Payments
NPI 1790375111 · ABINGDON, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,890 in 118 payments from 18 companies in 2025. Trend: 2023 $122 · 2024 $734 · 2025 $2,890
Food & beverage: $2,791Education: $99
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 15 | $557 |
| ABBVIE INC. | 23 | $432 |
| Takeda Pharmaceuticals U.S.A., Inc. | 18 | $421 |
| Madrigal Pharmaceuticals | 17 | $421 |
| Ardelyx, Inc. | 9 | $224 |
| PFIZER INC. | 8 | $162 |
| Phathom Pharmaceuticals, Inc. | 6 | $110 |
| QOL Medical, LLC | 3 | $92 |
| Ipsen Biopharmaceuticals, Inc | 3 | $84 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $79 |
Products named: TREMFYA, REZDIFFRA, CREON, ENTYVIO, IBSRELA, EOHILIA, VELSIPITY, VOQUEZNA.
Industry payments across MD — which companies pay providers there.
